相似文献
1
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment.
CMAJ. 2004 Jul 20;171(2):153-60. doi: 10.1503/cmaj.1030055.
2
[Clinicopathologic features of usual interstitial pneumonia and its differential diagnosis from idiopathic nonspecific interstitial pneumonia].
Zhonghua Bing Li Xue Za Zhi. 2004 Apr;33(2):100-4.
3
[Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases].
Vestn Rentgenol Radiol. 2015 Jul-Aug(4):5-11.
4
[Idiopathic pulmonary fibrosis].
Vnitr Lek. 2005 Dec;51(12):1375-84.
5
Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
Clin Exp Med. 2003 Sep;3(2):65-83. doi: 10.1007/s10238-003-0010-3.
6
Usual interstitial pneumonia and smoking-related interstitial fibrosis display epithelial to mesenchymal transition in fibroblastic foci.
Respir Med. 2014 Sep;108(9):1377-86. doi: 10.1016/j.rmed.2014.06.008. Epub 2014 Jul 17.
7
Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease.
BMC Med. 2015 Sep 24;13:241. doi: 10.1186/s12916-015-0479-0.
8
Right-Angled Traction Bronchiectasis in Differentiating Idiopathic Pulmonary Fibrosis Without Honeycombing From Idiopathic Nonspecific Interstitial Pneumonia.
Invest Radiol. 2020 Jun;55(6):387-395. doi: 10.1097/RLI.0000000000000651.
9
Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations.
Ann Diagn Pathol. 2015 Aug;19(4):269-76. doi: 10.1016/j.anndiagpath.2015.05.003. Epub 2015 May 13.
10
Idiopathic pulmonary fibrosis: current concepts.
Mayo Clin Proc. 1998 Nov;73(11):1085-101. doi: 10.4065/73.11.1085.
引用本文的文献
1
Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects.
Am J Stem Cells. 2024 Aug 25;13(4):191-211. doi: 10.62347/DAKS5508. eCollection 2024.
2
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers.
Int J Mol Sci. 2024 Jan 26;25(3):1562. doi: 10.3390/ijms25031562.
3
Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.
Biomedicines. 2023 Dec 8;11(12):3257. doi: 10.3390/biomedicines11123257.
4
Dissecting the effects of paraquat-induced pulmonary injury in rats using UPLC-Q-TOF-MS/MS-based metabonomics.
Toxicol Res (Camb). 2023 May 31;12(3):527-538. doi: 10.1093/toxres/tfad040. eCollection 2023 Jun.
5
Two-Pore-Domain Potassium Channel TREK-1 Mediates Pulmonary Fibrosis through Macrophage M2 Polarization and by Direct Promotion of Fibroblast Differentiation.
Biomedicines. 2023 Apr 26;11(5):1279. doi: 10.3390/biomedicines11051279.
6
Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers.
World J Transplant. 2023 Mar 18;13(3):58-85. doi: 10.5500/wjt.v13.i3.58.
7
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study.
Respir Res. 2022 Feb 16;23(1):32. doi: 10.1186/s12931-022-01946-6.
8
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway.
Bioengineered. 2021 Dec;12(1):3113-3124. doi: 10.1080/21655979.2021.1944020.
9
Reduced Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155.
Biomedicines. 2021 Apr 30;9(5):498. doi: 10.3390/biomedicines9050498.
10
The ER Stress/UPR Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.
Life (Basel). 2020 Dec 22;11(1):1. doi: 10.3390/life11010001.
本文引用的文献
1
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
N Engl J Med. 2004 Jan 8;350(2):125-33. doi: 10.1056/NEJMoa030511.
2
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia.
Chest. 2003 Oct;124(4):1215-23. doi: 10.1378/chest.124.4.1215.
3
Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.
Hum Genet. 2003 Nov;113(6):542-50. doi: 10.1007/s00439-003-1015-4. Epub 2003 Sep 6.
4
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
Eur Respir J. 2003 Aug;22(2):239-44. doi: 10.1183/09031936.03.00105202.
5
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.
J Thorac Cardiovasc Surg. 2003 Aug;126(2):469-75. doi: 10.1016/s0022-5223(03)00600-7.
6
Immunomodulatory agents for idiopathic pulmonary fibrosis.
Cochrane Database Syst Rev. 2003(3):CD003134. doi: 10.1002/14651858.CD003134.
7
Corticosteroids for idiopathic pulmonary fibrosis.
Cochrane Database Syst Rev. 2003;2003(3):CD002880. doi: 10.1002/14651858.CD002880.
8
Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.
Am J Respir Crit Care Med. 2003 Sep 1;168(5):531-7. doi: 10.1164/rccm.200210-1245OC. Epub 2003 Jun 5.
9
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.
Am J Respir Crit Care Med. 2003 Sep 1;168(5):543-8. doi: 10.1164/rccm.200209-1112OC. Epub 2003 May 28.
10
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42. doi: 10.1164/rccm.200211-1311OC. Epub 2003 May 28.
Zotero 插件